Today: 10 June 2026
Nike stock today: NKE edges up after-hours as UBS survey points to improving brand strength
30 December 2025
2 mins read

Nike stock today: NKE edges up after-hours as UBS survey points to improving brand strength

NEW YORK, December 29, 2025, 18:19 ET — After-hours.

  • Nike shares rose about 0.5% to $61.21 in after-hours trading.
  • A UBS Evidence Lab consumer survey flagged improving brand strength and product availability, a key turnaround marker.
  • U.S. stocks ended lower, with consumer discretionary lagging in thin year-end trade.

Nike shares ticked higher in after-hours trading on Monday after a UBS survey pointed to improving brand strength, while broader U.S. equities finished the day in the red.

The move matters now because investors have been looking for early evidence that Nike’s reset is showing up with consumers, not just in management talking points. Surveys on brand perception and product “findability” can lead reported sales, especially as Nike tries to rebuild distribution and reduce discounting.

Nike’s stock has been sensitive to incremental signals on demand and inventory, after recent results revived concerns about how long the turnaround will take. Traders have been quick to fade rallies when they see pressure on margins from promotions and supply-chain costs.

UBS said its Evidence Lab global sportswear survey showed improving brand momentum year over year, while maintaining a Neutral rating — broadly a hold-equivalent view — and a $62 price target, an analyst estimate of where the stock could trade over the next 12 months.

The survey also suggested two pillars of Nike’s strategy are gaining traction: customers reporting Nike products are easier to find in stores and online, and a rebound in the share of consumers who view Nike as “good for doing sports,” UBS said. Investing.com

In the broader market, the Dow fell 0.5%, the S&P 500 slipped 0.35% and the Nasdaq dropped 0.5% as investors pared risk late in the year. “In light volume trading, we’re seeing a reversal of what we saw over the last couple of days,” said Rob Haworth, senior investment strategist at U.S. Bank Wealth Management. Reuters

Consumer discretionary stocks were a weak spot, with the sector ETF down nearly 1% on the day, leaving Nike’s modest gain standing out against the group.

Nike’s session was choppy, with the stock trading between $60.31 and $61.72 before the after-hours print, as investors balanced survey optimism against ongoing execution risk.

The company is trying to reassert its edge in performance categories while repairing wholesale ties — selling more through third-party retailers — after years of pushing harder into direct-to-consumer channels. The aim is to improve reach and reduce reliance on heavy markdowns.

Nike’s latest quarterly report in mid-December showed revenue ahead of expectations but a hit to profitability as the company navigated tariff costs, discounting and weak demand in Greater China.

Competitive pressure remains a core part of the debate, with investors watching whether Nike can regain cultural relevance and shelf space versus newer, fast-growing rivals in running and lifestyle segments.

What traders are watching next is whether improved consumer signals translate into cleaner inventory, stronger full-price selling and steadier margins. The next major checkpoint is Nike’s next earnings report, expected around March 19, 2026, according to Zacks.

Near-term trading may stay headline- and flow-driven as year-end liquidity thins, with U.S. markets closed on Thursday for New Year’s Day.

Stock Market Today

  • NXP Semiconductors NXPI June 2027 Options Now Trading
    June 10, 2026, 12:28 PM EDT. NXP Semiconductors NV (NXPI) introduced new options contracts expiring in June 2027, offering investors extended time-value opportunities. The $290 strike put contract can be sold with a bid of $55.50, allowing potential purchase of shares at an effective cost basis of $234.50, factoring in premium. This strike is about 2% out-of-the-money with a 64% chance of expiring worthless, translating to an 18.78% annualized return if it does. On the call side, the $310 strike call has a bid of $58.50; selling it as a covered call at current share prices could yield a 24.67% return if the stock is called away by expiration. These long-dated options provide investors strategic opportunities to enhance yield or hedge positions amid NXPI's recent $295.59 trading price.

Latest articles

Ford Shares Slide as F-150 Aluminum Constraint Eases

Ford Shares Slide as F-150 Aluminum Constraint Eases

10 June 2026
Ford shares slid 3.2% to $14.47 despite Novelis restarting its Oswego aluminum plant, a key F-Series supplier, as investors now focus on how quickly supply ramps up to cut costs and boost production after months of disruption that forced Ford to cut its 2025 profit forecast and warn of up to $2 billion in charges.
Broadcom Shares Slip After $35 Billion AI Transaction, Guidance Jitters Linger

Broadcom Shares Slip After $35 Billion AI Transaction, Guidance Jitters Linger

10 June 2026
Broadcom shares plunged 4% to $376.42 despite unveiling a $35 billion AI infrastructure deal with Apollo and Blackstone, as investors fixated on last week’s softer-than-expected AI chip revenue guidance and ongoing concerns over high valuation, customer concentration, and margin risks tied to new AI financing models.
Palantir CEO Karp takes aim at AI spend by Anthropic, OpenAI

Palantir CEO Karp takes aim at AI spend by Anthropic, OpenAI

10 June 2026
Palantir shares edged up less than 1% to $132.66 after CEO Alex Karp told CNBC that enterprise customers are privately “unhappy” with frontier AI labs’ billing practices, as AI buyers face “sticker shock” and cost savings lag, while Palantir pitches its software and embedded engineers as a solution amid ongoing scrutiny of its NHS contract in Britain.
AMD stock today: Shares tick higher after hours as year-end tech selling weighs on chipmakers
Previous Story

AMD stock today: Shares tick higher after hours as year-end tech selling weighs on chipmakers

SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next
Next Story

SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next

Go toTop